Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.2K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to benchmark medical AI agents.

PLoS medicine·2026
Same author

AI-based selection of tumor regions for genomic profiling in neuropathology.

Neuro-oncology advances·2026
Same author

Generalizable and explainable deep learning for brain MRI: a multi-cohort evaluation of 3D architectures for age and sex prediction.

Brain informatics·2026
Same author

Integrating Participatory Social Innovation Into Requirements Engineering for AI Health Care Solutions: Case Study.

Journal of medical Internet research·2026
Same author

Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.

NPJ precision oncology·2026
Same author

Established machine learning matches tabular foundation models in clinical predictions.

BMC medical informatics and decision making·2026

Related Experiment Video

Updated: Jan 9, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient

Sonja Mathes1,2, Dyke Ferber3,4,5, Tobias Dreyer6,7

  • 1TUM School of Medicine and Health, Department of Dermatology, Technical University of Munich, Munich, Germany. sonja.mathes@mri.tum.de.

NPJ Precision Oncology
|December 4, 2025
PubMed
Summary

Large language models (LLMs) can structure real-world data for precision oncology. A new framework guides responsible LLM integration, addressing data bottlenecks and advancing biomarker discovery.

More Related Videos

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Jan 9, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.4K

Area of Science:

  • Oncology
  • Biomedical Informatics
  • Artificial Intelligence

Background:

  • Precision oncology relies on real-world data for biomarker and therapy identification.
  • Unstructured data presents a significant bottleneck in current precision oncology practices.
  • Large language models (LLMs) offer potential solutions for data structuring challenges.

Purpose of the Study:

  • To propose a framework for the responsible integration of LLMs into precision oncology.
  • To address current data-related bottlenecks in precision oncology research and application.
  • To guide multidisciplinary experts in leveraging LLMs for enhanced precision cancer care.

Main Methods:

  • Development of a framework for responsible LLM integration, co-created by multidisciplinary experts.
  • Establishment of five thematic dimensions and ten guiding principles for LLM implementation.
  • Application of the framework to a thought experiment involving uterine carcinosarcoma data.

Main Results:

  • The proposed framework provides a structured approach to utilizing LLMs in precision oncology.
  • The framework addresses key challenges in handling unstructured real-world data.
  • Illustrative application demonstrates the framework's utility in a specific cancer type.

Conclusions:

  • Responsible LLM integration is crucial for advancing precision oncology.
  • The framework facilitates the effective use of LLMs for biomarker discovery and therapy identification.
  • This approach supports overcoming data bottlenecks and enhances cancer care through AI.